This study tests whether the experimental drug telaglenastat can safely lower blood pressure in the lungs and improve heart and lung function in adults with pulmonary hypertension (PH). About 28 people with mild to moderate symptoms (classes II-III) will receive the drug on top o…
Phase: PHASE1, PHASE2 • Sponsor: Chan, Stephen, MD, PhD • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC